We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $21.7B
1-Year Est. Return 30.58%
This Fund
S&P 500
This Quarter Est. Return
+16.16%
1 Year Est. Return
+30.58%
3 Year Est. Return
+82.67%
5 Year Est. Return
+103.42%
10 Year Est. Return
+340.42%
AUM
$21.7B
AUM Growth
+$1.85B
Cap. Flow
-$80.7M
Cap. Flow %
-0.37%
Top 10 Hldgs %
29.3%
Holding
349
New
22
Increased
85
Reduced
186
Closed
8

Top Buys

Rank Stock Value
1
APO icon
Apollo Global Management
APO
+$134M
2
UNH icon
UnitedHealth
UNH
+$108M
3
CMI icon
Cummins
CMI
+$86.1M
4
TKO icon
TKO Group
TKO
+$72.8M
5
HUBB icon
Hubbell
HUBB
+$69.8M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$175M
2
LMT icon
Lockheed Martin
LMT
+$126M
3
PEP icon
PepsiCo
PEP
+$98.6M
4
AVGO icon
Broadcom
AVGO
+$90.2M
5
XOM icon
ExxonMobil
XOM
+$89.5M

Sector Composition

Rank Sector Weight
1 Technology 24.53%
2 Financials 16.18%
3 Healthcare 13.51%
4 Industrials 13.35%
5 Energy 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
126
Berkshire Hathaway Class B
BRK.B
$1.08T
$23M 0.11%
46,017
-758
-2% -$364K
INTU icon
127
Intuit
INTU
$97.9B
$22.8M 0.11%
87,421
+86,796
+13,887% +$30.2M
DOX icon
128
Amdocs
DOX
$6.57B
$21.8M 0.1%
432,132
-49,349
-10% -$3.03M
DKS icon
129
Dick's Sporting Goods
DKS
$12.1B
$21.6M 0.1%
+95,054
New +$21M
AVY icon
130
Avery Dennison
AVY
$13.5B
$20.9M 0.1%
128,442
-142,562
-53% -$23.2M
IEFA icon
131
iShares Core MSCI EAFE ETF
IEFA
$195B
$20.7M 0.1%
214,326
+4,522
+2% +$434K
EMR icon
132
Emerson Electric
EMR
$86.6B
$20.2M 0.09%
140,962
-4,695
-3% -$661K
ALLE icon
133
Allegion
ALLE
$13.4B
$20M 0.09%
142,589
-29,068
-17% -$3.95M
GOOG icon
134
Alphabet (Google) Class C
GOOG
$4.19T
$17.3M 0.08%
49,012
-793
-2% -$283K
PAYX icon
135
Paychex
PAYX
$45.2B
$17.3M 0.08%
176,107
-311,280
-64% -$29.5M
DOV icon
136
Dover
DOV
$26.8B
$13.9M 0.06%
61,868
-2,413
-4% -$526K
CW icon
137
Curtiss-Wright
CW
$22B
$13.7M 0.06%
18,014
-56
-0.3% -$41K
COHR icon
138
Coherent
COHR
$54.7B
$13.4M 0.06%
33,911
-1,394
-4% -$493K
HON icon
139
Honeywell
HON
$68.9B
$13.2M 0.06%
59,141
-60,876
-51% -$13.6M
CDW icon
140
CDW
CDW
$18.5B
$13.2M 0.06%
93,852
-7,513
-7% -$943K
HONA
141
Honeywell Aerospace
HONA
$51.5B
$13.1M 0.06%
+59,123
New +$13M
NVS icon
142
Novartis
NVS
$292B
$13.1M 0.06%
83,396
-2,292
-3% -$344K
SBUX icon
143
Starbucks
SBUX
$123B
$12.9M 0.06%
125,870
-1,278
-1% -$129K
NPO icon
144
Enpro
NPO
$6.33B
$12.8M 0.06%
33,843
-3,922
-10% -$1.22M
VEU icon
145
Vanguard FTSE All-World ex-US ETF
VEU
$70.4B
$12.7M 0.06%
152,193
-1,651
-1% -$135K
FSS icon
146
Federal Signal
FSS
$7.21B
$11.1M 0.05%
86,649
-9,445
-10% -$1.08M
INTC icon
147
Intel
INTC
$473B
$10.6M 0.05%
76,095
-847
-1% -$85.7K
CHE icon
148
Chemed
CHE
$6.84B
$10.5M 0.05%
22,619
+1,841
+9% +$774K
LFUS icon
149
Littelfuse
LFUS
$10.3B
$10.5M 0.05%
23,047
-7,397
-24% -$3.2M
BCPC
150
Balchem Corp
BCPC
$5.69B
$9.78M 0.05%
57,913
-4,590
-7% -$762K

Similar funds

Bahl & Gaynor's Q2 2026 Portfolio in Review

As of Q2 2026, Bahl & Gaynor held 349 positions worth $21.7B, up 9.3% from $19.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bahl & Gaynor's Q2 2026 filing shows 22 new, 85 increased, 186 reduced and 8 closed positions. Its largest new stake was TKO Group: 373,391 shares worth $75.2M. The largest sale was Johnson & Johnson, an estimated $175M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Bahl & Gaynor's largest Q2 2026 buy was TKO Group: 373,391 shares worth $75.2M.
  • Bahl & Gaynor added most to Apollo Global Management in Q2 2026, an estimated $134M increase.
  • Bahl & Gaynor's biggest Q2 2026 reduction was Johnson & Johnson, cutting an estimated $175M.
  • Bahl & Gaynor fully exited Oshkosh in Q2 2026, selling an estimated $8.49M.
  • Bahl & Gaynor's ten largest holdings make up 29% of its $21.7B portfolio in Q2 2026.
  • Bahl & Gaynor opened 22 new positions and closed 8 in Q2 2026.
  • Bahl & Gaynor's portfolio value rose 9.3% quarter-over-quarter to $21.7B.

Based on Bahl & Gaynor's 13F filing for Q2 2026, filed 13 Aug 2026.